IQVIA HLDGS DL-,01IQVIA HLDGS DL-,01IQVIA HLDGS DL-,01

IQVIA HLDGS DL-,01

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪33.21 B‬EUR
6.94EUR
‪1.23 B‬EUR
‪13.56 B‬EUR
‪178.22 M‬
Beta (1Y)
0.94

About IQVIA Holdings, Inc.


CEO
Ari Bousbib
Website
Headquarters
Durham
Founded
1950
FIGI
BBG004K9P2G0
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
I
IQV5590191
IQVIA Inc. 6.5% 15-MAY-2030
Yield to maturity
6.25%
Maturity date
May 15, 2030
I
IQV5590192
IQVIA Inc. 6.5% 15-MAY-2030
Yield to maturity
5.81%
Maturity date
May 15, 2030
I
IQV4831576
IQVIA Inc. 5.0% 15-MAY-2027
Yield to maturity
5.40%
Maturity date
May 15, 2027
I
IQV5763047
IQVIA Inc. 6.25% 01-FEB-2029
Yield to maturity
5.30%
Maturity date
Feb 1, 2029
I
QTRN4404230
IQVIA Inc. 5.0% 15-OCT-2026
Yield to maturity
5.25%
Maturity date
Oct 15, 2026
I
IQV5590167
IQVIA Inc. 5.7% 15-MAY-2028
Yield to maturity
5.18%
Maturity date
May 15, 2028
I
IQV5590165
IQVIA Inc. 5.7% 15-MAY-2028
Yield to maturity
5.02%
Maturity date
May 15, 2028
I
XS218994750
IQVIA 20/28 REGS
Yield to maturity
3.65%
Maturity date
Jun 15, 2028
I
5W8A
IQVIA 21/29 REGS
Yield to maturity
3.63%
Maturity date
Mar 15, 2029
I
XS203679815
IQVIA 19/28 REGS
Yield to maturity
3.62%
Maturity date
Jan 15, 2028
I
XS168438745
IQVIA 17/25 REGS
Yield to maturity
3.35%
Maturity date
Sep 15, 2025

Explore more bonds 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange IQVIA HLDGS DL-,01 stocks are traded under the ticker QTS.
We've gathered analysts' opinions on IQVIA HLDGS DL-,01 future price: according to them, QTS price has a max estimate of 262.12 EUR and a min estimate of 185.19 EUR. Watch QTS chart and read a more detailed IQVIA HLDGS DL-,01 stock forecast: see what analysts think of IQVIA HLDGS DL-,01 and suggest that you do with its stocks.
QTS reached its all-time high on Jan 3, 2022 with the price of 247.90 EUR, and its all-time low was 143.00 EUR and was reached on Jan 6, 2021. View more price dynamics on QTS chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track IQVIA HLDGS DL-,01 financials in yearly and quarterly reports right on TradingView.
IQVIA HLDGS DL-,01 is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
QTS earnings for the last quarter are 2.55 EUR per share, whereas the estimation was 2.54 EUR resulting in a 0.56% surprise. The estimated earnings for the next quarter are 2.95 EUR per share. See more details about IQVIA HLDGS DL-,01 earnings.
IQVIA HLDGS DL-,01 revenue for the last quarter amounts to ‪3.50 B‬ EUR, despite the estimated figure of ‪3.47 B‬ EUR. In the next quarter, revenue is expected to reach ‪3.74 B‬ EUR.
QTS net income for the last quarter is ‪255.97 M‬ EUR, while the quarter before that showed ‪338.90 M‬ EUR of net income which accounts for −24.47% change. Track more IQVIA HLDGS DL-,01 financial stats to get the full picture.
No, QTS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 18, 2024, the company has ‪87.00 K‬ employees. See our rating of the largest employees — is IQVIA HLDGS DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IQVIA HLDGS DL-,01 EBITDA is ‪2.96 B‬ EUR, and current EBITDA margin is 21.15%. See more stats in IQVIA HLDGS DL-,01 financial statements.
Like other stocks, QTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IQVIA HLDGS DL-,01 stock right from TradingView charts — choose your broker and connect to your account.